DRUG DOSES FRANK SHANN 2017 PDF

The booklet includes the dose of every drug commonly prescribed for systemic use in both adults and children, except for diagnostic agents. The booklet does not list the side effects of drugs, indications for their use, or modifications for renal or hepatic failure.


DOWNLOAD LINK:
MEDIAFIRE

BNF children 2017-2018 pdf

The BNF for Children (BNFC) 2017-2018 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. The resource addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence.

download link:
mediafire

BNF 74 pdf version

British National Formulary (BNF 74)

BNF 74 has been compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide. It provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

Contents

Content of the BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. The resource includes:

• Guidance on the drug management of common conditions
• Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient.
• Guidance on prescribing, monitoring, dispensing and adminstering medicines.

The content is updated every 6 months in print, making it an up-to-date source of prescribing advice for informed decision-making.

download link:

mediafire

BNF 73 march 2017 pdf

BNF 73 (March 2017) is the authoritative guide to prescribing, dispensing and administering medicines for all healthcare professionals.  Access to the latest edition of BNF is vital for healthcare professionals.

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, and administering medicines.

Not only does the BNF include a widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects and dosage. This allows treatment to be tailored to the individual needs of each patient.

The BNF is updated in print every six months by an expert team of pharmacists; validated by a network of leading clinicians from many spheres of clinical practice; and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited by regulatory bodies and courts as a source of authority.

New content and updates:
 Updated guidance for conditions including anal fissure, coeliac disease, dementia, exocrine pancreatic insufficiency, food allergy, multiple sclerosis and short bowel syndrome. New prescribing guidance for biological and biosimilar medicines.
 New drug monographs alirocumab, blinatumomab, brivaracetam, ceftobiprole, clevidipine, elvitegravir, isavuconazole, nivolumab and panobinostat.
 New safety information about fire risk with paraffin-based skin emollients on dressings and clothing and advice on minimising the risk of infections when being treated with idelalisib.
 Updated guidance on starting routine for oral progestogen-only contraceptives and the use of sodium glucose co-transporter 2 inhibitors as monotherapy for treating type 2 diabetes.

Download link:

mediafire

BNF Publication 2.0 for android

BNF Publications have developed an app that gives up-to-date offline reference to the British National Formulary (BNF) and the British National Formulary for Children (BNFC). Aimed at UK NHS healthcare professionals involved with prescribing, monitoring, supplying and administering medicines; the app provides essential information on the selection of safe and effective medicines for individual patients.

Please read the app Terms and Conditions [http://www.bnf.org/products/bnfbnfcapp/bnf-bnf-app-terms-and-conditions/] carefully before using this mobile application. Downloading the app will indicate your acceptance. If you do not agree to these Terms and Conditions, you may not use the app.

Features include:
· Offline browsing and searching of content of the BNF and BNFC
· The ability to switch between adult and child content
· Autocomplete search with navigation panes for treatment summaries, drug monographs and medicinal products
· Powerful interactions checker
· Clinical content updated every month
· Update notifications when a new update is available
· Optimised for smart phones and tablets

Download:
Mediafire

bnf for children sept 2016-2017

This Medical Association and Royal Pharmaceutical Society of Great Britain app-book for BNFCis developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.

Functions include:

• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes

The BNF for Children (BNFC) 2016-2017 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children.

Recommendations have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.

The BNF for Children 2016-2017 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.

Significant content updates include:

• New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
• Updated guidance for conditions including asthma and obesity
• Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
• New drug monographs including cholic acid
• New indications for adalimumab including chronic plaque psoriasis
• New safety information about the risk of osteonecrosis of the external auditory canal with bisphosphonates
• Guidance on suspected or confirmed drug allergies
• Evidence grading of BNF recommendations.

Unique benefits

• Shares the structure of the British National Formulary (BNF) and is designed to be used in paediatric and general practice settings
• Includes information on unlicensed use of medicines and provides details of unlicensed medicines that can be imported, manufactured by ‘special order' or prepared extemporaneously
• Covers the drug treatment of rare childhood conditions, provides guidance on specialist paediatric interventions and includes details of those medicines that are used in children in a different way to adults

International relevance

BNF and BNFC are the gold standard of drug information in English-speaking countries. They are used for constructing national formularies in other countries and to support regulatory work. They provide essential information when treating patients who have been prescribed medicines in the UK. Unlike many other local alternatives, both resources are completely independent from pharmaceutical industry influence with guidance that is based on best practice and real life evidence.

Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.

________________________________________

MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Elsevier, Wiley and more.


Download link:
Mediafire

BNF 73 march-sept 2017

This Medical Association and Royal Pharmaceutical Society of Great Britain app-book, British National Formulary (BNF) 73, is developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.

Important: This is a downloaded, offline app. The application is a single edition only; to stay updated it is recommended to purchase the forthcoming editions as they are revised twice yearly.

Functions include:

• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 73 (BNF) provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

NICE has accredited the editorial process used by the British National Formulary to produce its resources.*

New content updates in the BNF 73 include:

• Updated guidance for conditions including anal fissure, coeliac disease, dementia, exocrine pancreatic insufficiency, food allergy, multiple sclerosis and short bowel syndrome. New prescribing guidance for biological and biosimilar medicines.
• New drug monographs alirocumab, blinatumomab, brivaracetam, ceftobiprole, clevidipine, elvitegravir, isavuconazole, nivolumab and panobinostat.
• New safety information about fire risk with paraffin-based skin emollients on dressings and clothing and advice on minimising the risk of infections when being treated with idelalisib.
• Updated guidance on starting routine for oral progestogen-only contraceptives and the use of sodium glucose co-transporter 2 inhibitors as monotherapy for treating type 2 diabetes.

Improvements in the new edition:

Since the launch of the new format BNF we have actively sought your comments and feedback, and as a result have made the following improvements to this edition:

• Important safety information is displayed prominently within the monograph
• Class monographs (e.g. ACE inhibitors) are easy to navigate to from the individual monographs.

The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.


Authors: Joint Formulary Committee
________________________________________

MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Wiley, Elsevier and more.

Download link:
Mediafire